Sirona Biochem Corp V.SBM

New Press Release - Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim(TM) in Early 2025

VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF), also known as Sirona, is excited to share a new milestone in its journey. A recent exclusive video interview featuring Dr. Geraldine Deliencourt-Godefroy, Sirona's Chief...read article.

[tylerreddick]

I guess Howie realised that the twitter post wasn't getting much exposure, so putting out this NR will hopefully get more eyes on the prize.

[MirrorWorldMan]

I thought the same. Plans to do something at Sirona doesn't register with the market, it is non-news.  Only thing that will move the needle is actual revenue. And a lot of it.   

[biorun]

Probability of revenue will move the needle, doesn't have to be an after the fact post quarter 6 month behind data point. But I get your point.

[forhandlaren]

Abbvie launch milestone payment and/or anto-aging deal up-front for a region like India should be a good start.

[lscfa]

Slide 20 said Europe launch Q4 2025, now it's early 2025.... https://acrobat.adobe.com/id/urn:aaid:sc:EU:ada45a95-64d7-4b36-ad22-d265ca7c0b0b

[lscfa]

Europe mkt as big as NA, so double slide 21 revenue forecast of $21 million to $42 million